معرفی
Ingrid Holm is a Professor of Pediatrics at Harvard Medical School and an Associate in Pediatrics at Boston Children's Hospital (BCH), specializing in Medical Genetics and Endocrinology. She holds dual roles in clinical practice and academic research, focusing on the Ethical, Legal, and Social Implications (ELSI) of genomics, rare disease diagnostics, and newborn genomic screening. Her work integrates clinical care, translational research, and bioethics.
Education:
- B.A. Psychology, Brown University (1979)
- M.D., University of California, Los Angeles School of Medicine (1985)
- M.P.H. in Clinical Effectiveness, Harvard School of Public Health (2003)
Research Interests:
Dr. Holm's research addresses the ethical dimensions of genomic medicine, including the impact of genetic sequencing on newborn screening programs, rare disease diagnosis, and healthcare equity. She leads projects like the BabySeq Project (a randomized trial of genomic sequencing in newborns) and contributes to initiatives such as the Undiagnosed Diseases Network (UDN) and the eMERGE Network (exploring genomic medicine implementation). Her work also investigates genetic contributions to sudden unexpected pediatric deaths (SUD).
Key Contributions:
- PI on NIH-funded grants studying genomic result return and rare disease research
- Co-chair of the eMERGE Network's Return of Results/ELSI work group
- Leader of genetic studies in the Safe Passage Study (SIDS/SUDC)
Publications:
Her recent work emphasizes themes like genomic screening equity, parent decision-making in pediatric genomics, and the longitudinal impact of genetic diagnoses. Over 200 peer-reviewed articles reflect her multidisciplinary approach.
Awards:
- Fellow of the American Academy of Pediatrics
- Fellow of the American College of Medical Genetics and Genomics
- Elected Member of the Society for Pediatric Research
Labs/Teams:
Active in BCH's Genetics and Genomics Research Unit, the Harvard Center for Bioethics, and the Robert’s Program in Sudden Unexpected Death in Pediatrics.
